Talk:Heidelberg test

Proposed major revision — COI disclosure

I am the CEO of Heidelberg Medical, Inc., the manufacturer of the Heidelberg pH Capsule, and am therefore disclosing a conflict of interest. The current article is a stub with only four references, two of which are dead links or primary sources. I have prepared a substantially expanded draft below, sourced entirely from peer-reviewed publications indexed in PubMed and other academic databases. I am requesting that an uninvolved editor review the draft for neutrality, verifiability, and medical sourcing standards, and publish it if appropriate.

Heidelberg test
SynonymsHeidelberg pH capsule test, Heidelberg gastric analysis
PurposeAssessment of gastric acid secretion

The Heidelberg test is a medical diagnostic procedure that measures gastric acid secretion in real time using a swallowable radiotelemetry capsule. The patient ingests the capsule, which wirelessly transmits intragastric pH readings to an external receiver while a clinician administers a sodium bicarbonate challenge to assess the stomach's ability to produce acid.[1][2] The test is used to diagnose hypochlorhydria (reduced acid production), achlorhydria (absent acid production), and hyperchlorhydria (excessive acid production), as well as pyloric insufficiency, gastroparesis, dumping syndrome, and suspected bile reflux.[3]

History

The test originated at the University of Heidelberg in Germany, where physiologist H. G. Nöller and the electronics firm Telefunken developed a swallowable pH-sensing endoradiosonde in the late 1950s.[4] Nöller tested the device on more than 10,000 patients and developed the sodium bicarbonate challenge–reacidification protocol that remains the basis of the test today.[5] The device builds on the concept of the ingestible radio pill first described by Mackay and Jacobson in Nature in 1957[6] and applied clinically by Connell and Rowlands in Gut in 1960.[7] Early English-language validation studies appeared in The Lancet in 1964[1] and the Journal of Pharmaceutical Sciences in 1965.[8] The technology was commercialised in the United States by Heidelberg Medical, Inc. The device was legally marketed before the Medical Device Amendments of 1976 and is classified by the U.S. Food and Drug Administration as a Class I, 510(k)-exempt device under 21 CFR §876.1400.[9]

Procedure

The patient swallows the capsule in a fasted state. A thin medical-grade thread (tether) is typically attached to the capsule and taped to the patient's cheek to prevent premature migration from the stomach and to allow retrieval after testing. An external receiver displays the intragastric pH continuously on a graph.[1] Once a stable fasting pH is established, the clinician administers a measured dose of sodium bicarbonate solution, which temporarily neutralises gastric acid. The clinician then observes how quickly and completely the stomach's parietal cells reacidify the gastric contents. This challenge–reacidification cycle is repeated several times to assess the consistency and reserve capacity of acid secretion. A patient whose stomach fails to reacidify, or reacidifies slowly, may have hypochlorhydria or achlorhydria.[3][10] An untethered variant allows the capsule to transit the entire alimentary canal, producing a pH profile of the stomach, small intestine, and large intestine.[11] The test takes approximately 45 to 60 minutes, requires no sedation, and involves no recovery period.

Research applications

Gastric acid assessment

The test has been used in clinical research to assess gastric acid status in elderly patients,[12] patients at risk for atrophic gastritis,[13] patients with cystic fibrosis,[14] and healthy volunteers given proton pump inhibitors.[15]

Pharmaceutical science

The capsule has been widely used in pharmaceutical research to characterise gastrointestinal pH and gastric residence time in drug bioavailability studies. A series of studies by Mojaverian, Vlasses, and colleagues at Jefferson Medical College established the capsule as a reference tool for measuring the effects of food, posture, age, and gender on gastric transit.[16][17] The capsule was also used to demonstrate that elevated gastric pH impairs the absorption of ketoconazole but not fluconazole.[18]

Veterinary medicine

Heidelberg-type radiotelemetric pH capsules have been used to characterise gastrointestinal pH in beagle dogs,[19] pigs,[20] and calves.[21]

Comparison with other methods

Nasogastric tube aspiration, the historical reference method for measuring gastric acid output, requires intubation and is invasive. Catheter-based pH-metry and the Bravo capsule measure ambient oesophageal or gastric pH passively over extended periods and are designed primarily for evaluating gastroesophageal reflux disease. The SmartPill, a wireless motility and pH capsule, was used to measure gastrointestinal transit and pH but has been discontinued.[22] The Heidelberg test differs from these approaches in that it uses a dynamic challenge protocol — administering sodium bicarbonate and measuring the parietal cell response — rather than passively recording resting pH.[10]

Clinical context

The Heidelberg test is used primarily by practitioners of integrative medicine, naturopathic medicine, and functional medicine. It is not widely referenced in clinical practice guidelines issued by major gastroenterology societies, which typically evaluate acid-related disorders through endoscopy, ambulatory pH-impedance testing, and serum pepsinogen assays.[23]

See also

Gastric acid Hypochlorhydria Achlorhydria Parietal cell Ambulatory pH monitoring SmartPill Proton pump inhibitor

== References ==

  1. ^ a b c Connell, A. M.; Waters, T. E. (1964). "Assessment of gastric function by pH telemetering capsule". The Lancet. 2 (7353): 227–230. doi:10.1016/S0140-6736(64)90199-5. PMID 14163625.
  2. ^ Andres, M. R.; Bingham, J. R. (1970). "Tubeless gastric analysis with a radiotelemetering pill (Heidelberg capsule)". Canadian Medical Association Journal. 102 (10): 1087–1089. PMC 1930240. PMID 5521058.
  3. ^ a b Yarbrough, D. R.; McAlhany, J. C.; Weidner, M. G.; Cooper, N. (1969). "Evaluation of the Heidelberg pH capsule: method of tubeless gastric analysis". American Journal of Surgery. 117 (2): 185–192. doi:10.1016/0002-9610(69)90299-3. PMID 5773932.
  4. ^ Nöller, H. G. (1960). "Die Endoradiosonde, ein Mittel zur routinemäßigen, fortlaufenden, schlauchlosen Ermittlung der Säurewerte und der Pufferaktivität im Magen". Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Vol. 66. Springer. p. 496. doi:10.1007/978-3-642-96027-7_57.
  5. ^ Ewe, K.; Weis, H. (1968). "Magensäurebestimmung mit der Endoradiosonde (Heidelberger Kapsel) im Vergleich mit histologischem Schleimhautbefund und maximalem Histamintest". Deutsche Medizinische Wochenschrift. 93 (29): 1389–1393. doi:10.1055/s-0028-1110749.
  6. ^ Mackay, R. S.; Jacobson, B. (1957). "Endoradiosonde". Nature. 179 (4572): 1239–1240. Bibcode:1957Natur.179.1239M. doi:10.1038/1791239a0.
  7. ^ Connell, A. M.; Rowlands, E. N. (1960). "Wireless telemetering from the digestive tract". Gut. 1 (3): 266–272. doi:10.1136/gut.1.3.266. PMC 1413190. PMID 13688768.
  8. ^ Steinberg, W. H.; Mina, F. A.; Pick, P. G.; Frey, G. H. (1965). "Heidelberg capsule. I. In vitro evaluation of a new instrument for measuring intragastric pH". Journal of Pharmaceutical Sciences. 54 (5): 772–776. doi:10.1002/jps.2600540522. PMID 5845893.
  9. ^ "21 CFR §876.1400 — Stomach pH electrode". Electronic Code of Federal Regulations. Retrieved 2026-05-24.
  10. ^ a b Stack, B. H. (1969). "Use of the Heidelberg pH capsule in the routine assessment of gastric acid secretion". Gut. 10 (3): 245–246. doi:10.1136/gut.10.3.245. PMC 1552824. PMID 5781146.
  11. ^ Watson, W. C.; Paton, E. (1965). "Studies on intestinal pH by radiotelemetering". Gut. 6 (6): 606–612. doi:10.1136/gut.6.6.606. PMC 1552370. PMID 5857898.
  12. ^ Russell, T. L.; Berardi, R. R.; Barnett, J. L.; et al. (1993). "Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women". Pharmaceutical Research. 10 (2): 187–196. doi:10.1023/A:1018970323716. PMID 8456064.
  13. ^ Williamson, J. M.; Russell, R. I.; Goldberg, A. (1969). "A screening technique for the detection of achlorhydria using the Heidelberg capsule". Scandinavian Journal of Gastroenterology. 4 (4): 369–375. doi:10.3109/00365526909180618.
  14. ^ Youngberg, C. A.; Berardi, R. R.; Howatt, W. F.; et al. (1987). "Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects". Digestive Diseases and Sciences. 32 (5): 472–480. doi:10.1007/BF01296029. PMID 3568932.
  15. ^ Yago, M. R.; Frymoyer, A. R.; Smelick, G. S.; et al. (2013). "Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria". Molecular Pharmaceutics. 10 (11): 4032–4037. doi:10.1021/mp4003738. PMC 3946491. PMID 23980906.
  16. ^ Mojaverian, P.; Ferguson, R. K.; Vlasses, P. H.; et al. (1985). "Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition". Gastroenterology. 89 (2): 392–397. doi:10.1016/0016-5085(85)90342-8. PMID 3891497.
  17. ^ Mojaverian, P. (1996). "Evaluation of gastrointestinal pH and gastric residence time via the Heidelberg radiotelemetry capsule: pharmaceutical application". Drug Development Research. 38 (2): 73–85. doi:10.1002/(SICI)1098-2299(199606)38:2<73::AID-DDR1>3.0.CO;2-H.
  18. ^ Blum, R. A.; D'Andrea, D. T.; Florentino, B. M.; et al. (1991). "Increased gastric pH and the bioavailability of fluconazole and ketoconazole". Annals of Internal Medicine. 114 (9): 755–757. doi:10.7326/0003-4819-114-9-755. PMID 2012358.
  19. ^ Youngberg, C. A.; Wlodyga, J.; Schmaltz, S.; Dressman, J. B. (1985). "Radiotelemetric determination of gastrointestinal pH in four healthy beagles". American Journal of Veterinary Research. 46 (7): 1516–1521. PMID 4026035.
  20. ^ Hossain, M.; Abramowitz, W.; Watrous, B. J.; et al. (1998). "Variability in gastric pH and delayed gastric emptying in Yucatan miniature pigs". Pharmaceutical Research. 15 (4): 592–596. doi:10.1023/A:1018939204809.
  21. ^ Gränzer, W.; Menning, J.; Bruchner, H. (1973). "Intragastrale pH-Wertmessung beim Kalb mit einem Bioradiotelemetrie-System". Zeitschrift für Tierphysiologie Tierernährung und Futtermittelkunde. doi:10.1111/j.1439-0396.1973.tb01285.x.
  22. ^ Park, K.; Olver, I. N. (2013). "A new method for determining gastric acid output using a wireless pH sensing capsule". World Journal of Gastroenterology. 19 (26). doi:10.3748/wjg.v19.i26.4209. PMC 3703786.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  23. ^ Guilliams, T. G.; Drake, L. E. (2020). "Meal-time supplementation with betaine HCl for functional hypochlorhydria: what is the evidence?". Integrative Medicine. 19 (1): 32–36. PMC 7238915. PMID 32549862.

~2026-30949-50 (talk) 01:28, 25 May 2026 (UTC)[reply]

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.